General Catalyst Group Management »

Maze Therapeatics shares owned by General Catalyst Group Management

Quarter-by-quarter ownership of Maze Therapeatics (MAZE) shares owned by General Catalyst Group Management from 13F filings

Historical chart of General Catalyst Group Management investment in Maze Therapeatics

Tip: Access up to 7 years of quarterly data

All positions including Maze Therapeatics held by General Catalyst Group Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Maze Therapeatics by General Catalyst Group Management

Quarter filed Position value Share count Share price at filing
2025-09-30 $27M 1.0M 25.93
2025-06-30 $13M 1.0M 12.27
2025-03-31 $11M 1.0M 11.01

More positions owned by General Catalyst Group Management

Circle Internet Group Com Cl A (CRCL)
Samsara Com Cl A (IOT)
Figma Class A Com Stk (FIG)
Gitlab Class A Com (GTLB)
Arrivent Biopharma (AVBP)
Maze Therapeatics (MAZE)
Maplebear (CART)
Fractyl Health (GUTS)

View all positions for General Catalyst Group Management

Top funds holding Maze Therapeatics

Trv Gp Iv
Frazier Life Sciences Management
Arch Venture Corp
Deep Track Capital
Alphabet
AH Capital Management
Matrix Capital Management Company
Vanguard Group
BlackRock
VR Adviser
Logos Global Management
General Catalyst Group Management
Woodline Partners
TRV GP V
Marshall Wace

View all funds holding Maze Therapeatics